How Much Did THC Therapeutics Raise?
Funding & Key Investors

THC Therapeutics has successfully secured a significant capital injection, bringing its total funding to $50M. This latest infusion, characterized by a $25M strategic investment, underscores the market confidence in the firm's specialized approach to cannabis processing technology. As the company navigates the complexities of the OTC market, this financial backing serves as a critical catalyst for its ongoing operational expansion and technological development within the wellness sector.

The recent financing round highlights a pivotal moment for the Las Vegas-based entity, which has been aggressively pivoting its business model since its 2018 rebranding. By securing this capital, THC Therapeutics is well-positioned to accelerate the deployment of its proprietary hardware solutions while exploring broader market opportunities in the evolving landscape of cannabis and potential psychedelic therapeutics.

What is THC Therapeutics?

THC Therapeutics
ManufacturingIndustrial Machinery & Equipment

THC Therapeutics, Inc. operates as a publicly traded entity focused on the intersection of cannabis cultivation and advanced processing technology. Formerly known as Millennium Blockchain, the company has pivoted to prioritize the development of the dHydronator, a patented sanitizing cannabis dryer. This flagship technology is engineered to enhance quality control and efficiency in herb processing, addressing a critical bottleneck in the supply chain for premium cannabis producers. Beyond its hardware portfolio, the company maintains a growth strategy centered on the acquisition and integration of emerging cannabis brands, aiming to consolidate its footprint as a high-end supplier in the North American market.

How much funding has THC Therapeutics raised?

THC Therapeutics has raised a total of $50M across 2 funding rounds:

2021

Share Placement

$25M

Debt

$25M

Share Placement (2021): $25M with participation from Shefford Capital Partners

Debt (2021): $25M, investors not publicly disclosed

Key Investors in THC Therapeutics

Shefford Capital Partners

A specialized investment firm focused on business brokerage and professional development, providing strategic capital and operational guidance to emerging enterprises.

Undisclosed Investor

Undisclosed investor participating in the funding round.

What's next for THC Therapeutics?

Looking ahead, the strategic deployment of the $25M investment will likely focus on scaling the manufacturing and distribution of the dHydronator to meet increasing demand from commercial cultivators. Furthermore, the company is expected to leverage its current liquidity to pursue inorganic growth through targeted partnerships and acquisitions, effectively building out its brand ecosystem. As regulatory frameworks continue to shift, THC Therapeutics remains uniquely positioned to pivot into the emerging psychedelics market, utilizing its existing infrastructure to capture early-mover advantages in this high-growth, high-barrier-to-entry sector.

See full THC Therapeutics company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

ManufacturingPlastic, Packaging & ContainersBuilding Materials
Industrial Machinery & EquipmentManufacturingAutomotive Parts
Food & BeverageManufacturingAdvertising NetworksBusiness ServicesGrocery RetailRetail
Building MaterialsManufacturingFurniture

Frequently Asked Questions Regarding THC Therapeutics Financial Insights

What are the most recent funding rounds that THC Therapeutics has completed, and what were the funding rounds?
THC Therapeutics has recently completed 2 funding rounds: Share Placement on Sep 10, 2021, Debt on Sep 10, 2021.
What is the total amount of funding THC Therapeutics has raised to date?
THC Therapeutics has raised a total of $50M in funding to date.
How many funding rounds has THC Therapeutics completed?
THC Therapeutics has completed 2 funding rounds.
How much funding did THC Therapeutics raise in its most recent funding round?
THC Therapeutics raised $25M in its most recent funding round.
Who are the lead investors in THC Therapeutics's latest funding round?
The lead investor in THC Therapeutics's latest funding round was Shefford Capital Partners. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in THC Therapeutics's history?
The largest funding round in THC Therapeutics's history was $25M.
See more information about THC Therapeutics